Table 2.
Lesion characteristics
| Total group (n = 116) | |
|---|---|
| Diagnosis of the lesion | |
| In utero | 15 (13%) |
| At birth | 47 (41%) |
| < 1 year | 12 (10%) |
| 1–2 years | 10 (9%) |
| > 2 years | 30 (26%) |
| Type of malformation | |
| Pure lymphatic | 78 (67%) |
| Venolymphatic | 38 (33%) |
| Morphological subtype | |
| Macrocystic | 57 (49%) |
| Microcystic | 22 (19%) |
| Mixed | 37 (32%) |
| Anatomical location | |
| Head and neck | 57 (49%) |
| Thorax | 20 (17%) |
| Abdomen and pelvis | 14 (12%) |
| Upper extremity | 8 (7%) |
| Lower extremity | 10 (9%) |
| Abdomen/pelvis/lower extremity | 7 (6%) |
| Lesion-related complications | |
| Increase in size | 70 (60%) |
| Pain | 50 (43%) |
| Functional impairment | 37 (32%) |
| Cosmetically disturbing lesion | 34 (29%) |
| Infection | 13 (11%) |
| Bleeding | 11 (9%) |
| Oppression of other structures | 10 (9%) |
| Airway permeability threatened | 6 (5%) |